| Literature DB >> 32462732 |
Gerard M O'Reilly1,2,3, Rob D Mitchell1,2, Biswadev Mitra1,2,3, Michael P Noonan1,3,4, Ryan Hiller1, Lisa Brichko1,2,5, Carl Luckhoff1, Andrew Paton1,6, De Villiers Smit1,2, Peter A Cameron1,2.
Abstract
OBJECTIVE: In Australia, the current ED burden related to COVID-19 is from 'suspected' rather than 'confirmed' cases. The initial aim of the Registry for Emergency Care (REC) Project is to determine the impact of isolation processes on the emergency care of all patients.Entities:
Keywords: COVID-19; emergency; isolation; quality improvement; registry
Mesh:
Year: 2020 PMID: 32462732 PMCID: PMC7283792 DOI: 10.1111/1742-6723.13558
Source DB: PubMed Journal: Emerg Med Australas ISSN: 1742-6723 Impact factor: 2.279
|
To monitor ED presentations for presenting complaints consistent with conditions of public health importance (e.g. syndromic surveillance for respiratory infections with epidemic potential). Among all patients presenting to the ED (P), to determine and regularly monitor the impact of patient isolation (primary exposure variable (E)) during ED presentation Among clinically identified subgroups of patients presenting to the ED (defined by triage category, presenting complaint, first vital signs and/or ED callout criteria) (P), to determine and regularly monitor the impact of isolation (primary exposure variable (E)) during a patient's ED presentation Among all and clinically identified subgroups of patients presenting to the ED (defined by triage category, presenting complaint, first vital signs and/or ED callout criteria) (P), to determine and regularly monitor additional predictors and risk factors (other than isolation in the ED) (E/C) for clinical and system outcomes relevant to emergency care (O) (i.e. to use the REC to guide and improve care for all ED patients). To use the REC to provide useful, timely and regular (minimum of monthly) reports to inform and improve clinical care and system processes in the ED. |
Phase 1 (0–3 months).
Phase 2 (>3 months). C, comparator variable; E, exposure variable; O, outcome variable; P, study population.
| Variable | Type | Domain |
|---|---|---|
| Demographics and history | ||
| Age (years) | Continuous | 18 to 120 |
| Sex | Binary | Male or Female |
| Overseas travel | Binary | Yes or No |
| Close contact with confirmed COVID‐19 case | Binary | Yes or No |
| Residential care facility resident | Binary | Yes or No |
| Healthcare worker | Binary | Yes or No |
| Pregnancy | Binary | Yes or No |
|
Comorbidities Chronic respiratory disease Chronic cardiac disease Chronic hypertension Diabetes mellitus Smoker or ex‐smoker Obesity Current known cancer Immunosuppression Psychiatric illness‡ Other |
Binary Binary Binary Binary Binary Binary Binary Binary Binary Free text |
Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No |
| ED arrival | ||
| Interhospital transfer | Binary | Yes or No |
| Mode of arrival | Nominal | Types of transport |
| Triage category | Ordinal | 1 to 5 |
|
Team callout‡ Trauma Shocked trauma Cardiac arrest STEMI Stroke Sepsis Behaviour of concern |
Binary Binary Binary Binary Binary Binary Binary Binary |
Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No Yes or No |
| First pain score | Ordinal | 0 to 10 |
|
Isolation precautions in ED‡ Contact Droplet Airborne |
Binary Binary Binary |
Yes or No Yes or No Yes or No |
| Duration of time in isolation in ED | Continuous | 0 to Maximum |
| Presenting complaint | ||
| Coryza | Binary | Yes or No |
| Fever | Binary | Yes or No |
| Cough | Binary | Yes or No |
| Sore throat | Binary | Yes or No |
| Acute dyspnoea | Binary | Yes or No |
| Acute diarrhoea | Binary | Yes or No |
| Acute muscle aches | Binary | Yes or No |
| Acute fatigue | Binary | Yes or No |
| Anosmia and/or dysgeusia | Binary | Yes or No |
| Acute chest pain | Binary | Yes or No |
| Acute limb weakness | Binary | Yes or No |
| Acute injury | Binary | Yes or No |
| Acute altered conscious state (non‐injury) | Binary | Yes or No |
| Acute syncope | Binary | Yes or No |
| Acute abdominal pain | Binary | Yes or No |
| Acute anaphylaxis | Binary | Yes or No |
| Number of days since onset of first symptom | Continuous | 0 to 28 |
| Signs | ||
|
Vital signs Systolic blood pressure (mmHg) Heart rate (beats/min) Respiratory rate (breaths/min) Temperature (degrees Celsius) GCS AVPU |
Continuous Continuous Continuous Continuous Ordinal Ordinal |
0–300 0–300 0–50 20–50 3–15 A, V, P or U |
| Pupil size | Continuous | 0 to 20 mm |
| Pupil reactivity | Binary | Yes or No |
| Abnormalities on chest auscultation | Binary | Yes or No |
| Investigations | ||
| Time to first chest X‐ray (minutes) | Continuous | 0 to Maximum |
| Abnormalities on chest X‐ray | Nominal | Abnormality and Type |
| Time to first CT scan (minutes) | Continuous | 0 to Maximum |
| Abnormalities on chest CT | Nominal | Abnormality and Type |
| Blood test results (ED) | Numerical | Test specific |
| SARS‐CoV‐2 test result in ED | Binary | Positive or negative |
| SARS‐CoV‐2 test result – subsequent as inpatient | Binary | Positive or negative |
| Management in the ED | ||
| Clinical impression (Severity) | Ordinal | Mild to Extreme |
| Goals of care | Ordinal | A, B, C or D |
|
Oxygen delivery methods in the ED Nasal prongs† Mask† High flow nasal† Non‐invasive ventilation Invasive ventilation |
Binary Binary Binary Binary Binary |
Yes or No Yes or No Yes or No Yes or No Yes or No |
| Time of ETT in ED (minutes) | Continuous | 0 to Maximum |
| Time NIV commenced in ED (minutes) | Continuous | 0 to Maximum |
| Thoracostomy in ED | Binary | Yes or No |
| Time of thoracostomy in ED (minutes) | Continuous | 0 to Maximum |
| Blood products in ED | Binary | Yes or No |
| Time blood product transfusion commenced in ED | Continuous | 0 to Maximum |
| Antibiotics in ED | Binary | Yes or No |
| Time of first ED antibiotics | Continuous | 0 to Maximum |
| Inotropes/vasopressors in ED | Binary | Yes or No |
| Time inotropes/vasopressors commenced in ED | Continuous | 0 to Maximum |
| Time of first analgesia in ED | Continuous | 0 to Maximum |
| Disposition | ||
| ED disposition | Nominal | Disposition destinations |
| Length of stay in ED (minutes) | Continuous | 0 to Maximum |
| Mechanical ventilation during admission | Binary | Yes or No |
| Number of ventilation free days (days) | Continuous | 0 to Maximum |
| Hospital length of stay (days) | Continuous | 0 to Maximum |
| Death in hospital | Binary | Yes or No |
For COVED Project only (i.e. patients where COVID‐19 swab is performed in ED).
For REC Project only (i.e. additional to COVED Project variables).